Author

Mona Wang

Observed names: M. Wang, Wang, Mona

Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, Qilu Pharmaceutical Co., Ltd. (China)

Observed institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, Jiaxing University, Peking University Cancer Hospital, German Center for Infection Research, First Hospital of Jiaxing, Qilu Pharmaceutical Co., Ltd. (China), Technical University of Munich

ORCID: 0009-0005-8019-1461

Observed ORCID: 0009-0005-8019-1461

OpenAlex ID: A5060977752

Epithelial membrane protein 2: a novel biomarker for circulating tumor cell recovery in breast cancer

2018 · Q. Chen, L. Yao, et al. · Clinical & Translational Oncology · 15

A noninvasive multianalytical approach establishment for risk assessment and gastric cancer screening

2023 · Xiao‐Han Fan, Yang Zhang, et al. · International Journal of Cancer · 8

Gastric cancer detection based on cell‐free DNA in blood: A systematic review and meta‐analysis

2024 · Mona Wang, Xiaohan Fan, et al. · Clinical and Translational Discovery · 1

EP.13.30 Real-World Analysis of Treatment Patterns in Limited-Stage Small Cell Lung Cancer: Implications for Clinical Practice

2025 · S. Yu, X. Feng, et al. · Journal of Thoracic Oncology

1816eTiP Perioperative iparomlimab and tuvonralimab (QL1706) with or without chemotherapy in resectable non-small cell lung cancer (NSCLC): A two-arm, multicenter phase II trial in progress

2025 · F. Lv, K. Fei, et al. · Annals of Oncology

Circulating tumor cells (CTC) as a prognostic and predictive factor in Lung Cancer Patients–a pilot study in PUMCH

2008 · X. Zhou, L. Li, et al. · Journal of Clinical Oncology

Works count: 7

Citation count: 24

H-index: 2

I10-index: 1